Literature DB >> 9216643

Gliomas are driven by glycolysis: putative roles of hexokinase, oxidative phosphorylation and mitochondrial ultrastructure.

S Oudard1, E Boitier, L Miccoli, S Rousset, B Dutrillaux, M F Poupon.   

Abstract

To elucidate the reasons for glycolytic deviation commonly found in brain tumors, hexokinase (HK) activity, mitochondria-HK binding, oxidative phosphorylation and mitochondrial ultrastructure were studied in 4 human xenografted gliomas. Lactate/pyruvate ratios were increased 3-4 fold and HK activity was of 2-4 fold lower than that of normal rat brain tissue, used as the control. The mitochondria-bound HK (mHK) fraction varied considerably and represented 9 to 69% of the total HK of that normal rat brain. The respiratory activity of glioma mitochondria, assessed by polarography and spectrophotometry, was within the normal range. However, the mitochondrial content of gliomas was lower than in the rat brain tissue, as revealed by the markedly decreased, activities of two unrelated mitochondrial enzymes, cytochrome c oxidase and citrate synthase in glioma homogenates. Electron microscopical studies confirmed the reduced number of mitochondria in 3 out of the 4 gliomas. Profound alterations of mitochondrial ultrastructure, namely of cristae and matrix densities, were observed in the 4 gliomas. The intercrista space was wider in all gliomas and the crista area was larger in 3 out of the 4 gliomas than in normal rat brain. Finally, the outer membrane of glioma mitochondria interacted intimately and extensively with the rough endoplasmic reticulum (RER) and/or nuclear membrane. These results suggest that, because of the very low content of normally functioning mitochondria, gliomas shift their energy metabolism towards a high-level glycolysis to generate their cellular ATP supply, probably through RER-mitochondria interactions and transformation-dependent redistribution of particulate HK from non-mitochondrial to mitochondrial receptors.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9216643

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  36 in total

1.  Extracellular glutamate and other metabolites in and around RG2 rat glioma: an intracerebral microdialysis study.

Authors:  P F Behrens; H Langemann; R Strohschein; J Draeger; J Hennig
Journal:  J Neurooncol       Date:  2000-03       Impact factor: 4.130

2.  D-Amino acid oxidase-induced oxidative stress, 3-bromopyruvate and citrate inhibit angiogenesis, exhibiting potent anticancer effects.

Authors:  S M El Sayed; R M Abou El-Magd; Y Shishido; K Yorita; S P Chung; D H Tran; T Sakai; H Watanabe; S Kagami; K Fukui
Journal:  J Bioenerg Biomembr       Date:  2012-07-17       Impact factor: 2.945

3.  Hexokinase 'binding sites' of normal and tumoral human brain mitochondria.

Authors:  A Golestani; M Nemat-Gorgani
Journal:  Mol Cell Biochem       Date:  2000-12       Impact factor: 3.396

4.  Provocative Question: Should Ketogenic Metabolic Therapy Become the Standard of Care for Glioblastoma?

Authors:  Thomas N Seyfried; Laura Shelton; Gabriel Arismendi-Morillo; Miriam Kalamian; Ahmed Elsakka; Joseph Maroon; Purna Mukherjee
Journal:  Neurochem Res       Date:  2019-04-25       Impact factor: 3.996

5.  Growth control of C6 glioma in vivo by nerve growth factor.

Authors:  Shigeyoshi Kimura; Atsuo Yoshino; Yoichi Katayama; Takao Watanabe; Takao Fukushima
Journal:  J Neurooncol       Date:  2002-09       Impact factor: 4.130

6.  Short-term calorie and protein restriction provide partial protection from chemotoxicity but do not delay glioma progression.

Authors:  Sebastian Brandhorst; Min Wei; Saewon Hwang; Todd E Morgan; Valter D Longo
Journal:  Exp Gerontol       Date:  2013-02-21       Impact factor: 4.032

7.  Function of carbonic anhydrase IX in glioblastoma multiforme.

Authors:  Martin A Proescholdt; Marsha J Merrill; Eva-Maria Stoerr; Annette Lohmeier; Fabian Pohl; Alexander Brawanski
Journal:  Neuro Oncol       Date:  2012-10-16       Impact factor: 12.300

8.  Caloric restriction reduces edema and prolongs survival in a mouse glioma model.

Authors:  Yong-Sheng Jiang; Fu-Rong Wang
Journal:  J Neurooncol       Date:  2013-05-24       Impact factor: 4.130

9.  Dietary restriction reduces angiogenesis and growth in an orthotopic mouse brain tumour model.

Authors:  P Mukherjee; M M El-Abbadi; J L Kasperzyk; M K Ranes; T N Seyfried
Journal:  Br J Cancer       Date:  2002-05-20       Impact factor: 7.640

10.  In vitro growth environment produces lipidomic and electron transport chain abnormalities in mitochondria from non-tumorigenic astrocytes and brain tumours.

Authors:  Michael A Kiebish; Xianlin Han; Hua Cheng; Thomas N Seyfried
Journal:  ASN Neuro       Date:  2009-05-27       Impact factor: 4.146

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.